PHYSIOTHERAPY BASED APPROACHES TO PATIENT REHABILITATION AND DENTAL EXPERTISE FOR JAW AND FACIAL PAIN
With
Darron Goralsky,
CEO & Clinical Director
Melbourne TMJ & Facial Pain Centre
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Melbourne | November 2025
Darron Goralsky is the Founder, CEO and Clinical Director of Melbourne TMJ & Facial Pain Centre, one of Australia’s leading multidisciplinary clinics dedicated to the assessment and management of temporomandibular disorders (TMD) and craniofacial pain.
With over 30 years of experience treating TMJ, facial and neck-related conditions, Darron originally trained as a Physiotherapist in South Africa, completing post graduate certifications in Manipulative Therapy. After his arrival in Melbourne he then continued with studies in Craniosacral Therapy. Early in his career, Darron identified a major gap in how jaw and facial pain conditions were managed—recognising the need for a collaborative approach that integrates manual therapy and other physiotherapy based approaches to patient rehabilitation, and dental expertise.
This insight led to the development of the Goralsky Craniomandibular Method (GCMM), a structured multidisciplinary protocol combining physiotherapy principles with dental and medical collaboration. Darron has lectured to many dental and allied health groups, was part of a 4 person lecture team for a one day course on TMD for the University of Melbourne’s Dental School, and presented at the 2019 ANZAOP Conference. In 2024, Darron was an invited speaker at the Myofocus Functional Health Symposium in Melbourne, presenting on multidisciplinary management of TMD and orofacial pain. Darron has also presented a 5-hour Masterclass for dentists as part of Dr Damian Teo’s Mini Residency in TMD & Sleep for the last 5 years. Building on this momentum, he developed and successfully delivered his inaugural 2-day intensive professional education program for dental professionals, The 5-Step TMD Protocol Course, in October 2025.
A passionate educator and mentor, Darron now focuses on training and developing clinicians in his evidence-based approach. His growing team includes TMJ physiotherapists, osteopaths, dentists, and orofacial myofunctional therapists, a breathing educator and a GP working collaboratively to deliver comprehensive patient care. Darron is an active member of the Australian Physiotherapy Association (APA), the American Academy of Craniofacial Pain (AACP), and the Australia and New Zealand Academy of Orofacial Pain (ANZAOP).
Source: Supplied and adapted
-
Addressing Wound Management
The cost of chronic wounds in Australia is estimated to be $3 Billion per year, impacting 420,000 Australians. Not only is this a national economic concern, but more importantly, is the suffering the person may be going through.
Australian Health Journal met with Hayley Ryan, Board Director and Chair at Wounds Australia and Director at WoundRescue to hear her work in chronic wound management, palliative wounds and pressure injury prevention to comfort those living with a wound.
-
Valuing the Contribution of Exercise Physiologists in Australia
Exercise physiologists are saving the Australian health system at least $940 million across six chronic health conditions every three years, a Deloitte Access Economics report has found.
Backed by three decades of rigorous peer-reviewed science, exercise physiology delivers services to 243,000 Australians per week, translating to more than 1.16 million unique patients annually, primarily through 9,800 Accredited Exercise Physiologists (AEPs) nationwide.
-
Investments to address health inequities in Prostate Cancer Care
Income, education, geographical location, and discrimination based on ethnicity, race, gender and sexual orientation, are only a fraction of factors that can negatively affect a person’s quality of cancer care. This is defined as the “equity gap” and it’s costing people their lives.
Timed to coincide with World Cancer Day 4th February 2025, Movember announced prostate cancer investment of $5.5 million. Eighteen grants (16 proposals and 2 community development grants) are slated to directly tackle inequities in prostate cancer care. The funding will be over three years with the grants spread across five countries – six in Canada, five in the United Kingdom, three in Australia, three in the United States and one in Ireland – each having a specific focus population and care area.
